Lemaitre Vascular (LHU) Hedge Fund Trading Activity
Trend: â–Ľ Hedge Funds Decreased Holdings by 200.5K Shares Last Quarter
Hedge Fund Holdings in LHU
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity​
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 Andrew Alkon | EntryPoint Capital, LLC | New | 100.00% | $449,294 | 0.18% | ||
 James E. Flynn | Deerfield Management Company, LP | Reduced | -13.83% | $2,093,596 | 0.03% | ||
 Kenneth Tropin | Graham Capital Management, L.P. | Reduced | -29.26% | $409,555 | <0.01% |
FAQ
Which hedge funds hold Lemaitre Vascular?
The hedge funds that hold the most shares in Lemaitre Vascular are James E. Flynn, Andrew Alkon and Kenneth Tropin.
Are hedge funds buying or selling DE:LHU?
In the last quarter hedge funds have Decreased their holdings in Lemaitre Vascular by 200.5K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Lemaitre Vascular stock?
Warren Buffet currently does not own shares in Lemaitre Vascular.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
